BRITISH JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2246729, encodeId=92e52246e297f, content=大家会Under review后直接desk rejection吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89519541539, createdName=ms8000000101118959, createdTime=Sun Jan 05 20:03:45 CST 2025, time=2025-01-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=)]

2025-01-05 ms8000000101118959 来自北京

大家会Under review后直接desk rejection吗

3 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246729, encodeId=92e52246e297f, content=大家会Under review后直接desk rejection吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89519541539, createdName=ms8000000101118959, createdTime=Sun Jan 05 20:03:45 CST 2025, time=2025-01-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=)]

2024-10-31 暗影的太阳来自湖南省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：食管;手术;新辅助
经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。
也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246729, encodeId=92e52246e297f, content=大家会Under review后直接desk rejection吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89519541539, createdName=ms8000000101118959, createdTime=Sun Jan 05 20:03:45 CST 2025, time=2025-01-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=)]

2021-06-10 godweiZ

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：食管癌
经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。

257 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246729, encodeId=92e52246e297f, content=大家会Under review后直接desk rejection吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89519541539, createdName=ms8000000101118959, createdTime=Sun Jan 05 20:03:45 CST 2025, time=2025-01-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=)]

2024-05-10 ms3000000760145879 来自上海

Under consideration 25天了救命这合理吗？？？

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246729, encodeId=92e52246e297f, content=大家会Under review后直接desk rejection吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89519541539, createdName=ms8000000101118959, createdTime=Sun Jan 05 20:03:45 CST 2025, time=2025-01-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=)]

2024-07-30 ms3000000242801209 来自河南省

这本期刊为什么被北方某医院给预警了？

72 0

[GetPortalCommentsPageByObjectIdResponse(id=2246729, encodeId=92e52246e297f, content=大家会Under review后直接desk rejection吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89519541539, createdName=ms8000000101118959, createdTime=Sun Jan 05 20:03:45 CST 2025, time=2025-01-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=)]

2023-09-18 nenee 来自湖北省

偏重的研究方向：乳腺癌;肿瘤
经验分享：请问under consideration 两周了是怎么回事呢

157 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246729, encodeId=92e52246e297f, content=大家会Under review后直接desk rejection吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89519541539, createdName=ms8000000101118959, createdTime=Sun Jan 05 20:03:45 CST 2025, time=2025-01-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=)]

2022-06-23 ms3000000859573514

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤治疗
经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火

188 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246729, encodeId=92e52246e297f, content=大家会Under review后直接desk rejection吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89519541539, createdName=ms8000000101118959, createdTime=Sun Jan 05 20:03:45 CST 2025, time=2025-01-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=)]

2020-01-08 18900911270haoliangdut

请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表:
有救

138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救

307 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246729, encodeId=92e52246e297f, content=大家会Under review后直接desk rejection吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89519541539, createdName=ms8000000101118959, createdTime=Sun Jan 05 20:03:45 CST 2025, time=2025-01-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=)]

2023-08-27 docL 来自上海

偏重的研究方向：分子标记物
经验分享：100天了，还没找到审稿人

171 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246729, encodeId=92e52246e297f, content=大家会Under review后直接desk rejection吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89519541539, createdName=ms8000000101118959, createdTime=Sun Jan 05 20:03:45 CST 2025, time=2025-01-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=)]

2022-09-12 Glori

审稿速度:3.0
偏重的研究方向：肿瘤
经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久

199 13

展开13条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务